China · Delayed Price · Currency is CNY Sinocare Statistics
Total Valuation
Sinocare has a market cap or net worth of CNY 9.61 billion. The enterprise value is 9.85 billion.
| Market Cap | 9.61B |
| Enterprise Value | 9.85B |
Important Dates
The last earnings date was Friday, October 23, 2026.
| Earnings Date | Oct 23, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Sinocare has 531.91 million shares outstanding. The number of shares has decreased by -2.18% in one year.
| Current Share Class | 531.91M |
| Shares Outstanding | 531.91M |
| Shares Change (YoY) | -2.18% |
| Shares Change (QoQ) | -1.05% |
| Owned by Insiders (%) | 52.49% |
| Owned by Institutions (%) | 7.51% |
| Float | 247.20M |
Valuation Ratios
The trailing PE ratio is 38.48 and the forward PE ratio is 19.76. Sinocare's PEG ratio is 0.19.
| PE Ratio | 38.48 |
| Forward PE | 19.76 |
| PS Ratio | 1.90 |
| PB Ratio | 2.74 |
| P/TBV Ratio | 4.73 |
| P/FCF Ratio | 24.77 |
| P/OCF Ratio | 17.97 |
| PEG Ratio | 0.19 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 15.08, with an EV/FCF ratio of 25.40.
| EV / Earnings | 38.89 |
| EV / Sales | 1.95 |
| EV / EBITDA | 15.08 |
| EV / EBIT | 19.86 |
| EV / FCF | 25.40 |
Financial Position
The company has a current ratio of 1.27, with a Debt / Equity ratio of 0.30.
| Current Ratio | 1.27 |
| Quick Ratio | 0.77 |
| Debt / Equity | 0.30 |
| Debt / EBITDA | 1.62 |
| Debt / FCF | 2.73 |
| Interest Coverage | 12.83 |
Financial Efficiency
Return on equity (ROE) is 6.73% and return on invested capital (ROIC) is 10.93%.
| Return on Equity (ROE) | 6.73% |
| Return on Assets (ROA) | 4.98% |
| Return on Invested Capital (ROIC) | 10.93% |
| Return on Capital Employed (ROCE) | 12.38% |
| Weighted Average Cost of Capital (WACC) | 3.50% |
| Revenue Per Employee | 1.01M |
| Profits Per Employee | 50,551 |
| Employee Count | 4,994 |
| Asset Turnover | 0.81 |
| Inventory Turnover | 3.16 |
Taxes
In the past 12 months, Sinocare has paid 80.99 million in taxes.
| Income Tax | 80.99M |
| Effective Tax Rate | 25.12% |
Stock Price Statistics
The stock price has decreased by -3.32% in the last 52 weeks. The beta is -0.12, so Sinocare's price volatility has been lower than the market average.
| Beta (5Y) | -0.12 |
| 52-Week Price Change | -3.32% |
| 50-Day Moving Average | 16.85 |
| 200-Day Moving Average | 16.42 |
| Relative Strength Index (RSI) | 53.25 |
| Average Volume (20 Days) | 14,158,132 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Sinocare had revenue of CNY 5.05 billion and earned 253.26 million in profits. Earnings per share was 0.47.
| Revenue | 5.05B |
| Gross Profit | 2.60B |
| Operating Income | 495.89M |
| Pretax Income | 322.44M |
| Net Income | 253.26M |
| EBITDA | 637.65M |
| EBIT | 495.89M |
| Earnings Per Share (EPS) | 0.47 |
Balance Sheet
The company has 1.12 billion in cash and 1.06 billion in debt, with a net cash position of 60.79 million or 0.11 per share.
| Cash & Cash Equivalents | 1.12B |
| Total Debt | 1.06B |
| Net Cash | 60.79M |
| Net Cash Per Share | 0.11 |
| Equity (Book Value) | 3.50B |
| Book Value Per Share | 6.02 |
| Working Capital | 591.63M |
Cash Flow
In the last 12 months, operating cash flow was 534.61 million and capital expenditures -146.83 million, giving a free cash flow of 387.78 million.
| Operating Cash Flow | 534.61M |
| Capital Expenditures | -146.83M |
| Depreciation & Amortization | 141.76M |
| Net Borrowing | 96.31M |
| Free Cash Flow | 387.78M |
| FCF Per Share | 0.73 |
Margins
Gross margin is 51.55%, with operating and profit margins of 9.83% and 5.02%.
| Gross Margin | 51.55% |
| Operating Margin | 9.83% |
| Pretax Margin | 6.39% |
| Profit Margin | 5.02% |
| EBITDA Margin | 12.64% |
| EBIT Margin | 9.83% |
| FCF Margin | 7.68% |
Dividends & Yields
Sinocare does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | 6.60% |
| FCF Payout Ratio | n/a |
| Buyback Yield | 2.18% |
| Shareholder Yield | 2.18% |
| Earnings Yield | 2.60% |
| FCF Yield | 4.04% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Analyst Forecast
The average price target for Sinocare is 23.14, which is 28.13% higher than the current price. The consensus rating is "Buy".
| Price Target | 23.14 |
| Price Target Difference | 28.13% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 9.78% |
| EPS Growth Forecast (3Y) | 103.87% |
Stock Splits
The last stock split was on July 16, 2018. It was a forward split with a ratio of 1.2.
| Last Split Date | Jul 16, 2018 |
| Split Type | Forward |
| Split Ratio | 1.2 |
Scores
Sinocare has an Altman Z-Score of 3.67 and a Piotroski F-Score of 7.
| Altman Z-Score | 3.67 |
| Piotroski F-Score | 7 |